SOURCE: Inforsense, Ltd.

InforSense, Ltd.

June 03, 2009 08:00 ET

InforSense and febit Announce OEM for Geniom Platform

febit Embeds InforSense Platform to Support Flexible Microarray Analysis

LONDON and CAMBRIDGE, MA--(Marketwire - June 3, 2009) - InforSense Ltd., the leading provider of next generation business and scientific intelligence solutions, today announced that febit has integrated key components of the InforSense platform to provide the data analysis and visualization functionality in febit's new Geniom flexible microarray platform. febit has embedded the InforSense platform, workflows and visualizations and delivers them to customers with each Geniom instrument.

The InforSense platform provides rich data analytics and rapid application development capabilities. InforSense's VisualSense offers sophisticated, interactive web based visualization of scientific data. The Geniom platform from febit delivers a completely configurable microarray environment as well as a growing portfolio of catalogue biochips that accelerate research and reduce the associated costs. Key applications include targeted sequence capture prior to Next Generation Sequencing (NGS), as well as classical transcriptomic applications. When used together InforSense and febit enable a wide range of pharmaceutical and medical research customers to more effectively analyze and view their data to improve disease understanding.

"Geniom's microarrays are completely configurable if needed, requiring very flexible tools for quality control tests, experimental design, data analysis, and visualization," said Anthony Caruso, VP of Global Informatics at febit. "InforSense's strength lies in the speed and flexibility with which analytical applications can be developed, modified, and delivered to end-users. Our applications require a platform with the ability to handle massive amounts of data, which can then be boiled down and presented in manageable size pieces to our end-users. Developing on the InforSense platform has enabled us to focus on the bioinformatics and computational algorithms, which are core to our business."

"Geniom is accelerating the pace of research by delivering a fast and flexible process for defining and analyzing microarrays. We are delighted that febit have chosen InforSense software as a key component of this groundbreaking product," said Nick Goode, VP Marketing and Alliances, InforSense. "One of the strengths of the InforSense platform is the ease with which our technology can be embedded within other products from scientific equipment to healthcare instruments and reporting. Scientific and health-related data analysis and visualization continues to be our core market and we are seeing increasing interest in companies who wish to incorporate our capabilities into their products."

About febit

febit enables scientists to read, write and understand the code of life: DNA. febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. The product portfolio spans various instruments, assay protocols and bio-analytical services and is complemented by bioinformatics software, services and consulting. For its main applications HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing as well as for protein-coding and non-coding transcriptomic profiling, the highly elaborated microfluidics of the patented Geniom Biochip offer the highest degree of automation, flexibility and efficiency throughout the field. For more information about febit and its products please visit www.febit.com.

About InforSense

InforSense delivers fast answers to complex questions in business, healthcare and life science. InforSense's next generation business and scientific intelligence solutions provide ROI in days, not months. Designed to handle today's complex business environments, where traditional BI products often fall short, the InforSense platform has the power and agility to integrate, analyze and visualize any data in any way. Around the world, leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies rely on InforSense. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts. For more information, visit www.inforsense.com and on Twitter at www.twitter.com/inforsense.

InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Contact Information

  • Contact:
    Danielle Guinebertiere
    InforSense
    617 547 2500 x230
    Email Contact